Novel Combinatorial Approaches to Tackle the Immunosuppressive Microenvironment of Prostate Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Combinatorial Approaches to Tackle the Immunosuppressive Microenvironment of Prostate Cancer
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 5, Pages 1145
Publisher
MDPI AG
Online
2021-03-08
DOI
10.3390/cancers13051145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment
- (2020) Naoki Horikawa et al. BRITISH JOURNAL OF CANCER
- Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial
- (2020) Masanori Noguchi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Overall survival and second primary malignancies in men with metastatic prostate cancer
- (2020) Juha Mehtälä et al. PLoS One
- T Cell Dysfunction and Exhaustion in Cancer
- (2020) Zhen Zhang et al. Frontiers in Cell and Developmental Biology
- Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
- (2020) Sean Harrison et al. CANCER CAUSES & CONTROL
- Prostate cancer cell‐intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone
- (2020) Katie L Owen et al. EMBO REPORTS
- Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancer
- (2020) Daniel H. Kwon et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis
- (2020) Francesco Bonollo et al. Cancers
- ADRB2-Targeting Therapies for Prostate Cancer
- (2019) George Kulik Cancers
- Continuous infusion 5-fluorouracil (5FU) as a novel treatment for heavily pretreated prostate cancer patients: An update.
- (2019) Charlotte Manogue et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostate cancer incidence and mortality among men using statins and non-statin lipid-lowering medications
- (2019) Maria I. Van Rompay et al. EUROPEAN JOURNAL OF CANCER
- Prostatic Acid Phosphatase (PAP) Predicts Prostate Cancer Progress in a Population-Based Study: The Renewal of PAP?
- (2019) Huan Xu et al. DISEASE MARKERS
- Statins Use and the Risk of Prostate Cancer in Ischemic Heart Disease Patients in Taiwan
- (2019) Wei Ho et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Exosomal miRNA-107 induces myeloid-derived suppressor cell expansion in gastric cancer
- (2019) WeiHong Ren et al. Cancer Management and Research
- African KhoeSan ancestry linked to high-risk prostate cancer
- (2019) Desiree C. Petersen et al. BMC Medical Genomics
- The STAT3 inhibitor galiellalactone inhibits the generation of MDSC‐like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors
- (2019) Rebecka Hellsten et al. PROSTATE
- Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression
- (2019) Antonino Bruno et al. Frontiers in Immunology
- Survival outcomes from a cumulative analysis of worldwide observational studies on sequential use of new agents in metastatic Castration-Resistant Prostate Cancer (mCRPC)
- (2019) Orazio Caffo et al. Clinical Genitourinary Cancer
- The β2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells
- (2019) Peder R. Braadland et al. MOLECULAR CANCER RESEARCH
- MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers
- (2019) Livingstone Fultang et al. EBioMedicine
- Optimizing prostate biopsy techniques
- (2019) Altan Omer et al. CURRENT OPINION IN UROLOGY
- Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
- (2019) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate Cancer
- (2019) Douglas G. McNeel et al. JOURNAL OF CLINICAL ONCOLOGY
- Neutrophil elastase-mediated proteolysis of the tumor suppressor p200 CUX1 promotes cell proliferation and inhibits cell differentiation in APL
- (2019) Lihua Yu et al. LIFE SCIENCES
- The prognostic value of myeloid derived suppressor cell level in hepatocellular carcinoma: A systematic review and meta-analysis
- (2019) Xinyu Zhang et al. PLoS One
- Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis
- (2018) Leen Naji et al. ANNALS OF FAMILY MEDICINE
- Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis, and metastasis in prostate cancer progression
- (2018) Wenliang Li et al. ASIAN JOURNAL OF ANDROLOGY
- Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium
- (2018) Artitaya Lophatananon et al. BRITISH JOURNAL OF CANCER
- Targeting myeloid-derived suppressor cells for cancer immunotherapy
- (2018) Yijun Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association With Overall Survival
- (2018) Emmanuel S. Antonarakis et al. CLINICAL CANCER RESEARCH
- High-Fat Diet-Induced Inflammation Accelerates Prostate Cancer Growth via IL6 Signaling
- (2018) Takuji Hayashi et al. CLINICAL CANCER RESEARCH
- Novel PAP-derived vaccine for the treatment of advanced prostate cancer
- (2018) P. Le Vu et al. EUROPEAN JOURNAL OF CANCER
- Twelve-month prostate volume reduction after MRI-guided transurethral ultrasound ablation of the prostate
- (2018) David Bonekamp et al. EUROPEAN RADIOLOGY
- Randomized Trial of Partial Gland Ablation with Vascular Targeted Phototherapy versus Active Surveillance for Low Risk Prostate Cancer: Extended Followup and Analyses of Effectiveness
- (2018) Inderbir S. Gill et al. JOURNAL OF UROLOGY
- mTOR inhibitors for treatment of low-risk prostate cancer
- (2018) Michael A. Liss et al. MEDICAL HYPOTHESES
- Intra vs Inter Cross-Resistance Determines Treatment Sequence between Taxane and AR-Targeting Therapies in Advanced Prostate Cancer
- (2018) Alan P. Lombard et al. MOLECULAR CANCER THERAPEUTICS
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
- (2018) Fredrick R. Schumacher et al. NATURE GENETICS
- Potentiating prostate cancer immunotherapy with oncolytic viruses
- (2018) Patrick Lee et al. Nature Reviews Urology
- Cellular plasticity and the neuroendocrine phenotype in prostate cancer
- (2018) Alastair H. Davies et al. Nature Reviews Urology
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways
- (2018) Xiaofan Guo et al. ONCOGENE
- Neutrophil elastase in the tumor microenvironment
- (2018) Irina Lerman et al. STEROIDS
- Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer
- (2018) Elena Jachetti et al. Cancer Immunology Research
- Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
- (2018) Viktor Fleming et al. Frontiers in Immunology
- Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and Sepsis
- (2018) Kim Ohl et al. Frontiers in Immunology
- Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
- (2018) Amila Suraweera et al. Frontiers in Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Short interval of biopsy to robotic-assisted laparoscopic radical prostatectomy does not render any adverse effects on the perioperative outcomes
- (2018) Minke He et al. MEDICINE
- IL-23 secreted by myeloid cells drives castration-resistant prostate cancer
- (2018) Arianna Calcinotto et al. NATURE
- Myeloid-derived suppressor cells inhibit T cell activation through nitrating LCK in mouse cancers
- (2018) Shan Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations
- (2018) E. David Crawford et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis
- (2018) Dragan Ilic et al. BMJ-British Medical Journal
- Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancer
- (2018) Jason M. Redman et al. Journal for ImmunoTherapy of Cancer
- Initial outcomes of local anaesthetic freehand transperineal biopsies in the outpatient setting
- (2018) Francesca Kum et al. BJU INTERNATIONAL
- Prognostic role of myeloid-derived suppressor cells in cancers: a systematic review and meta-analysis
- (2018) Lisha Ai et al. BMC CANCER
- Depression induced neuropeptide Y secretion promotes prostate cancer growth by recruiting myeloid cells
- (2018) Yan Cheng et al. CLINICAL CANCER RESEARCH
- STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers
- (2018) Dayson Moreira et al. CLINICAL CANCER RESEARCH
- Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
- (2018) Priyamvada Jayaprakash et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor-infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?
- (2018) Timothy E. Krueger et al. PROSTATE
- Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancer
- (2018) Katsunobu Hagihara et al. OncoImmunology
- Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
- (2018) Fatima Karzai et al. Journal for ImmunoTherapy of Cancer
- Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer
- (2017) Barbra A. Dickerman et al. INTERNATIONAL JOURNAL OF CANCER
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combination treatment with docetaxel and histone deacetylase inhibitors downregulates androgen receptor signaling in castration-resistant prostate cancer
- (2017) Sang Eun Park et al. INVESTIGATIONAL NEW DRUGS
- The Diagnosis and Treatment of Prostate Cancer
- (2017) Mark S. Litwin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer
- (2017) Tomasz M. Beer et al. JOURNAL OF CLINICAL ONCOLOGY
- Infiltrating Myeloid Cells Exert Protumorigenic Actions via Neutrophil Elastase
- (2017) Irina Lerman et al. MOLECULAR CANCER RESEARCH
- Effective combinatorial immunotherapy for castration-resistant prostate cancer
- (2017) Xin Lu et al. NATURE
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?
- (2017) V R Minciacchi et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis
- (2017) Shiou-Ling Jian et al. Cell Death & Disease
- PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis
- (2017) Daniela Basso et al. Oncotarget
- Myeloid-Derived Suppressor Cells
- (2017) Dmitry I. Gabrilovich Cancer Immunology Research
- Unfolding anti-tumor immunity: ER stress responses sculpt tolerogenic myeloid cells in cancer
- (2017) Juan R. Cubillos-Ruiz et al. Journal for ImmunoTherapy of Cancer
- Response to: ‘Issues with anti-Gr1 antibody-mediated myeloid-derived suppressor cell depletion’ by Xinget al
- (2016) Xiang-Yang Wang et al. ANNALS OF THE RHEUMATIC DISEASES
- MDSCs in cancer: Conceiving new prognostic and therapeutic targets
- (2016) Francesco De Sanctis et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Clonotypic Diversification of Intratumoral T Cells Following Sipuleucel-T Treatment in Prostate Cancer Subjects
- (2016) Nadeem Sheikh et al. CANCER RESEARCH
- Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial
- (2016) Emmanuel S. Antonarakis et al. CLINICAL CANCER RESEARCH
- Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody
- (2016) George A. Dominguez et al. CLINICAL CANCER RESEARCH
- CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation
- (2016) Vinit Kumar et al. IMMUNITY
- Familial Risk and Heritability of Cancer Among Twins in Nordic Countries
- (2016) Lorelei A. Mucci et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Myeloid-derived suppressor cells in gastrointestinal cancers: A systematic review
- (2016) Armin Hirbod-Mobarakeh et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- CLL-cell-mediated MDSC induction by exosomal miR-155 transfer is disrupted by vitamin D
- (2016) H Bruns et al. LEUKEMIA
- Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis
- (2016) Z Deng et al. ONCOGENE
- Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy
- (2016) Inès Dufait et al. Oncotarget
- Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22–CCR4 axis
- (2016) Aerken Maolake et al. Oncotarget
- The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells
- (2016) Chunwan Lu et al. OncoImmunology
- Cryosurgery would be An Effective Option for Clinically Localized Prostate Cancer: A Meta-analysis and Systematic Review
- (2016) Liang Gao et al. Scientific Reports
- A New Histone Deacetylase Inhibitor, MHY219, Inhibits the Migration of Human Prostate Cancer Cells via HDAC1
- (2015) Umasankar De et al. Biomolecules & Therapeutics
- Decision aids for localized prostate cancer treatment choice: Systematic review and meta-analysis
- (2015) Philippe D. Violette et al. CA-A CANCER JOURNAL FOR CLINICIANS
- TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients
- (2015) D. M. S. Hossain et al. CLINICAL CANCER RESEARCH
- Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial
- (2015) Eva Haglind et al. EUROPEAN UROLOGY
- Valproic acid inhibits the invasion of PC3 prostate cancer cells by upregulating the metastasis suppressor protein NDRG1
- (2015) Jae Eun Lee et al. GENETICS AND MOLECULAR BIOLOGY
- The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era
- (2015) Jaquelyn L. Jahn et al. INTERNATIONAL JOURNAL OF CANCER
- A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195
- (2015) B. J. Eigl et al. INVESTIGATIONAL NEW DRUGS
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of beta-blockers on prostate cancer mortality: a meta-analysis of 16,825 patients
- (2015) Hua Lu et al. OncoTargets and Therapy
- Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
- (2015) G. Wang et al. Cancer Discovery
- Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
- (2015) Rikke B. Holmgaard et al. Cell Reports
- Breaking bad habits: Targeting MDSCs to alleviate immunosuppression in prostate cancer
- (2015) Sumanta K. Pal et al. OncoImmunology
- β-Adrenergic Receptor Signaling in Prostate Cancer
- (2015) Peder Rustøen Braadland et al. Frontiers in Oncology
- Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer
- (2014) Manja Idorn et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Belinostat: First Global Approval
- (2014) Raewyn M. Poole DRUGS
- A Systematic Review and Meta-analysis of Tobacco Use and Prostate Cancer Mortality and Incidence in Prospective Cohort Studies
- (2014) Farhad Islami et al. EUROPEAN UROLOGY
- Overdiagnosis and Overtreatment of Prostate Cancer
- (2014) Stacy Loeb et al. EUROPEAN UROLOGY
- ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R–mediated apoptosis
- (2014) Thomas Condamine et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells
- (2014) P. Sinha et al. JOURNAL OF IMMUNOLOGY
- Activated Lymphocyte Recruitment Into the Tumor Microenvironment Following Preoperative Sipuleucel-T for Localized Prostate Cancer
- (2014) Lawrence Fong et al. JNCI-Journal of the National Cancer Institute
- Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
- (2014) Eugene D Kwon et al. LANCET ONCOLOGY
- Neutrophil elastase-dependent cleavage compromises the tumor suppressor role of EMILIN1
- (2014) Eliana Pivetta et al. MATRIX BIOLOGY
- Pharmacologic Suppression of JAK1/2 by JAK1/2 Inhibitor AZD1480 Potently Inhibits IL-6-Induced Experimental Prostate Cancer Metastases Formation
- (2014) L. Gu et al. MOLECULAR CANCER THERAPEUTICS
- Metabolic control of YAP and TAZ by the mevalonate pathway
- (2014) Giovanni Sorrentino et al. NATURE CELL BIOLOGY
- Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer
- (2014) Anna Bill-Axelson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical presentation of prostate cancer in Black South Africans
- (2014) Elizabeth A. Tindall et al. PROSTATE
- Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
- (2014) S. L. Highfill et al. Science Translational Medicine
- Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells
- (2014) M A Babcook et al. Cell Death & Disease
- Does the autonomic nervous system contribute to the initiation and progression of prostate cancer?
- (2013) Sabatino Ventura et al. ASIAN JOURNAL OF ANDROLOGY
- A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells
- (2013) Nabanita Patra et al. BIOMEDICINE & PHARMACOTHERAPY
- A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
- (2013) Dana E. Rathkopf et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pharmacologic Inhibition of Jak2-Stat5 Signaling By Jak2 Inhibitor AZD1480 Potently Suppresses Growth of Both Primary and Castrate-Resistant Prostate Cancer
- (2013) L. Gu et al. CLINICAL CANCER RESEARCH
- Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice
- (2013) Jaimy M. S. Saif et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways
- (2013) Patrick L. Raber et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison
- (2013) Davide Brusa et al. INTERNATIONAL JOURNAL OF UROLOGY
- Mesenchymal Stem Cells Tune the Development of Monocyte-Derived Dendritic Cells Toward a Myeloid-Derived Suppressive Phenotype through Growth-Regulated Oncogene Chemokines
- (2013) H.-W. Chen et al. JOURNAL OF IMMUNOLOGY
- Optimization of Initial Prostate Biopsy in Clinical Practice: Sampling, Labeling and Specimen Processing
- (2013) Marc A. Bjurlin et al. JOURNAL OF UROLOGY
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
- (2013) T Karantanos et al. ONCOGENE
- Autonomic Nerve Development Contributes to Prostate Cancer Progression
- (2013) C. Magnon et al. SCIENCE
- Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways
- (2013) F Bruzzese et al. Cell Death & Disease
- Multipotent Human Mesenchymal Stromal Cells Mediate Expansion of Myeloid-Derived Suppressor Cells via Hepatocyte Growth Factor/c-Met and STAT3
- (2013) B. Linju Yen et al. Stem Cell Reports
- Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer
- (2012) Nadeem A. Sheikh et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Radical Prostatectomy versus Observation for Localized Prostate Cancer
- (2012) Timothy J. Wilt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models
- (2012) Li Shen et al. PLoS One
- Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
- (2011) K. Fizazi et al. EUROPEAN JOURNAL OF CANCER
- A Critical Role for STAT3 Transcription Factor Signaling in the Development and Maintenance of Human T Cell Memory
- (2011) Andrea M. Siegel et al. IMMUNITY
- An Interleukin-21- Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells
- (2011) Weiguo Cui et al. IMMUNITY
- Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
- (2011) Tangying Lu et al. JOURNAL OF CLINICAL INVESTIGATION
- Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
- (2011) Barbara Molon et al. JOURNAL OF EXPERIMENTAL MEDICINE
- S100A8 and S100A9: New Insights into Their Roles in Malignancy
- (2011) Geetha Srikrishna Journal of Innate Immunity
- Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells
- (2011) Rebecka Hellsten et al. PLoS One
- The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study
- (2011) Jayaprakash Karkera et al. PROSTATE
- A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer
- (2010) Dana Rathkopf et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer
- (2010) T. B. Dorff et al. CLINICAL CANCER RESEARCH
- Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
- (2010) Sean J. Whittaker et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
- (2010) S. Nagaraj et al. JOURNAL OF IMMUNOLOGY
- Histone Deacetylase Inhibitor Potentiates Anticancer Effect of Docetaxel via Modulation of Bcl-2 Family Proteins and Tubulin in Hormone Refractory Prostate Cancer Cells
- (2010) Jung Jin Hwang et al. JOURNAL OF UROLOGY
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer
- (2010) Mark D. Hurwitz et al. RADIOTHERAPY AND ONCOLOGY
- Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
- (2009) L. R. Molife et al. ANNALS OF ONCOLOGY
- Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862)
- (2009) Deborah Bradley et al. CANCER
- Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer
- (2009) F. M. Speetjens et al. CLINICAL CANCER RESEARCH
- Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters
- (2009) Kathleen Ebelt et al. EUROPEAN JOURNAL OF CANCER
- Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
- (2009) C. A. Corzo et al. JOURNAL OF IMMUNOLOGY
- Clinical Significance of Measuring Prostate-Specific Antigen
- (2009) Borros M. Arneth Labmedicine
- Immunosuppressive CD14+HLA-DRlow/−monocytes in prostate cancer
- (2009) Stanimir Vuk-Pavlović et al. PROSTATE
- Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
- (2008) K. Movahedi et al. BLOOD
- Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
- (2008) W Weichert et al. BRITISH JOURNAL OF CANCER
- Phase I Pharmacokinetic and Pharmacodynamic Study of LAQ824, a Hydroxamate Histone Deacetylase Inhibitor with a Heat Shock Protein-90 Inhibitory Profile, in Patients with Advanced Solid Tumors
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
- Induction of myeloid-derived suppressor cells by tumor exosomes
- (2008) Xiaoyu Xiang et al. INTERNATIONAL JOURNAL OF CANCER
- Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer
- (2008) Brittney Jung-Hynes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
- (2008) Pingyan Cheng et al. JOURNAL OF EXPERIMENTAL MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search